Abstract
Melasma is a common pigment disorder that has various causes and its appropriate management is linked to correct assessment and quantification. Several active compounds and treatments can be used based on different mechanisms of action, ranging from inhibition of melanogenesis to physical removal of melanin within the epidermis. This article will review the benefits and side effects of the main active and combination compounds used currently in the management of disorders of hyperpigmentation.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.